What is USANA Health Sciences's net debt / EBITDA?

USANA Health Sciences (USNA) reported net debt / EBITDA of -2× in Q4 2025.

What is the long-term trend for USANA Health Sciences's net debt / EBITDA?

Over 3 years (2022 to 2025), USANA Health Sciences's net debt / EBITDA has grown at a -3.9% compound annual growth rate (CAGR), from -2.3× to -2×.

What does net debt / EBITDA mean?

Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.

USANA Health Sciences USNA Net debt / EBITDA

Net debt / EBITDA at other companies

Nature's Sunshine ProductsNATR

-1.6×-0.3×

HerbalifeHLF

2.8×-0.9×

BellRing BrandsBRBR

3.7×+1.7×

United Natural FoodsUNFI

8.5×-0.8×

US FoodsUSFD

3.1×+0.1×

Universal CorporationUVV

3.7×+0.8×

Other financials

Income statement

See full

Revenue$250.2M+0.3%

Gross profit$190.8M-3.2%

Operating income$13.9M-11.5%

Net income$7.5M-20.1%

EPS (diluted)$0.41-16.3%

Balance sheet

See full

Cash & equivalents$165.7M-9.2%

Total debt$18.0M+10.8%

Total equity$543.6M+2.6%

Total assets$739.0M-1.0%

Cash flow

See full

Operating cash flow$9.8M-37.0%

CapEx$2.6M-5.6%

Free cash flow$7.1M-43.9%

Valuation

See full

Market cap$363.35M-36.1%

P/E18.1×+7.8×

P/S0.4×-0.3×

Profitability

See full

Gross margin77.6%-3.0pp

Operating margin3.8%-2.7pp

Net margin1.9%-4.4pp

FCF margin5.7%-1.1pp

Returns & leverage

See full

Return on equity3.2%-7.6pp

Debt / equity0×0.0×

Current ratio2.5×+0.5×

Where this comes from

Calculated from USANA Health Sciences’s reported figures.

net debt/ebitda=-2×

Based on the most recent quarter.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is USANA Health Sciences's net debt / EBITDA?: USANA Health Sciences (USNA) reported net debt / EBITDA of -2× in Q4 2025.
What is the long-term trend for USANA Health Sciences's net debt / EBITDA?: Over 3 years (2022 to 2025), USANA Health Sciences's net debt / EBITDA has grown at a -3.9% compound annual growth rate (CAGR), from -2.3× to -2×.
What does net debt / EBITDA mean?: Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.